Commercial Insight: Top 20 Therapy Cancer Brands - Key Brands Set To Consolidate Advantage As Compet

By Author: Manjula Menon
Total Articles: 1477
Comment this article

Cancer therapy brand sales totaled over $30 billion in the seven major markets in 2007, growing by 20.1% since 2006. The high growth of this market makes it attractive to companies keen to emulate the blockbuster status achieved by several brands. However, with several impending patent expiries due, companies will need to work hard to maximize their return throughout the lifecycle of their brands.

Scope of this report

Current and future overview of the cancer therapy brands market in 2007 and 2017

Individual country forecasts for the Top 20 cancer therapy brands in each of the seven major markets

Segmentation and analysis of market dynamics by country sales, drug class, indication, company and impacted events

Detailed product profiles and discussion of assumptions and events used in forecast analysis

Research and analysis highlights

The Top 20 cancer therapy brands in the seven major markets contributed the majority ($26.1 billion, 85%) of cancer therapy brand sales in 2007. It forecasts the total market to grow to $62.4 billion by 2017 at a CAGR of 7%. The Top 20 brands in ...
... 2017 will still contribute a high proportion of this (80%) with sales reaching $50.2 billion.

Targeted therapies will increasingly dominate the Top 20 cancer brands leaderboard, accounting for 12 of the Top 20 brands in the seven major markets in 2017. It forecasts Avastin to become the leading cancer therapy brand, facilitated by further indication expansion and high physician familiarity.

Genentech/Roche are the dominant force in the market with an oncology portfolio including the three leading cancer therapy brands (Rituxan, Avastin and Herceptin). The companies are set to continue this dominance, with Rituxan, Avastin and Herceptin forecast to remain the top three brands in 2017, achieving aggregate 7MM sales of over $23 billion.

For more information Kindly visit the website : http://www.bharatbook.com/detail.asp?id=82015

Or Contact us on :
Tel No : (+9122 )27578668 , 27579438
Fax: (+9122 )27579131

Address :
Bharat Book Bureau,
207,Hermes Atrium,
Sector-11
P.O Box 54,
CBD Belapur,
Navi Mumbai - 400614.

Bharat BooK Bureau is the leading market research information aggregator which provides reports, Company profiles, newletters, country info. and online databases for the past twenty years to corportate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies. It helps global companies to know different market before starting up business / expanding in different countries across the world. www.bharatbook.com is one stop shop for the business intelligence information requirements.